Integrated ophthalmology and medical optics platform, with three premium locations and over 20 years of operational history. The business delivers exceptional financial performance, with a premium EBITDA margin of 64% in 2025, supported by an “asset-light” operating model, a stable team, and organic growth of 11–15% annually.
The company is completely debt-free, generates predictable cash flow, and offers immediate regional scaling potential. The transaction includes all operational assets, team, and standardized processes.
Products and services
The business offers a wide range of ophthalmological medical services, including diagnosis and treatment for various eye conditions, using advanced Optical Coherence Tomography (OCT) technology.
It sells prescription and sunglasses, contact lenses, and various optical accessories, providing a complete solution for customer needs.
Operations
Scalable operational model
Infrastructure includes state-of-the-art medical equipment and 3 optimized, strategically positioned locations
Stable and high-performing team: 4 ophthalmologists with strong local reputation and 10 specialists (optometrists, technicians, support staff) with an average tenure of 12–18 years
Standardized processes, efficient operational flow
Integrated supply chain from diagnosis to eyewear production, with minimal lead time and reduced costs
Replicable model in nearby cities with minimal investment.
Tangible and intangible assets
Modern medical equipment (OCT, autorefractometers, biomicroscopes, etc.)
Fully equipped lens assembly laboratory
Full inventory (value: €120,000, included in the price)
Loyal patient base built over 25 years
Contracts with premium suppliers
Local brand with excellent reputation
Full team with active employment contracts
Standardized and documented operational processes
